UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005128
Receipt number R000005621
Scientific Title Functional imaging for advanced cancer treatment
Date of disclosure of the study information 2011/02/23
Last modified on 2016/09/01 09:21:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Functional imaging for advanced cancer treatment

Acronym

FACT

Scientific Title

Functional imaging for advanced cancer treatment

Scientific Title:Acronym

FACT

Region

Japan


Condition

Condition

Advanced cancer

Classification by specialty

Hepato-biliary-pancreatic medicine Pneumology Hematology and clinical oncology
Gastrointestinal surgery Hepato-biliary-pancreatic surgery Chest surgery
Breast surgery Obstetrics and Gynecology Urology
Radiology Oral surgery Neurosurgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of the most appropriate diagnostic method to detect resistant tumor tissues in advanced cancer using PET probes.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Analyzing the correlation between PET tracer accumulation and effects of the treatment, such as radiotherapy and chemotherapy.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Functional PET imaging

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Advanced cancer

Key exclusion criteria

Patients who do not take any treatments.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidehiko Okazawa

Organization

University of Fukui

Division name

Biomedical Imaging Research Center

Zip code


Address

23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, Fukui, 910-1193 Japan

TEL

0776-61-8491

Email

okazawa@u-fukui.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hidehiko Okazawa

Organization

University of Fukui

Division name

Biomedical Imaging Research Center

Zip code


Address

23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, Fukui, 910-1193 Japan

TEL

0776-61-8491

Homepage URL


Email

bircfukui@gmail.com


Sponsor or person

Institute

Biomedical Imaging Research Center, University of Fukui

Institute

Department

Personal name



Funding Source

Organization

JST

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 02 Month 23 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications

http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0155635

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2010 Year 11 Month 30 Day

Date of IRB


Anticipated trial start date

2010 Year 12 Month 01 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry

2017 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 02 Month 23 Day

Last modified on

2016 Year 09 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005621


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name